BusinessPositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over YearBy Nasdaq OMXNov 14, 2017, 1:00 PM UTC
BusinessPositiveID Subsidiary ExcitePCR Announces Board of AdvisorsBy Nasdaq OMXSep 26, 2017, 12:00 PM UTC
BusinessPositiveID Successfully Detects Ebola Virus on its Firefly Dx Prototype SystemBy Nasdaq OMXAug 8, 2017, 12:00 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 25, 2017, 12:04 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 25, 2017, 12:04 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 25, 2017, 12:04 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 25, 2017, 12:04 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 24, 2017, 12:33 PM UTC
